HIGH-DOSE THIOTEPA WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR METASTATIC MALIGNANT-MELANOMA - RESULTS OF PHASE-I AND PHASE-II STUDIES OF THE NORTH-AMERICAN BONE-MARROW TRANSPLANTATION GROUP

被引：33

作者：

WOLFF, SN

HERZIG, RH

FAY, JW

LEMAISTRE, CF

FREILAHR, D

LOWDER, J

BOLWELL, B

GIANNONE, L

HERZIG, GP

机构：

[1] CLEVELAND CLIN EDUC FDN, CLEVELAND, OH 44106 USA

[2] WASHINGTON UNIV, ST LOUIS, MO 63130 USA

[3] BAYLOR UNIV, MED CTR, DALLAS, TX USA

[4] UNIV TEXAS SAN ANTONIO, SAN ANTONIO, TX 78285 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 02期

关键词：

D O I：

10.1200/JCO.1989.7.2.245

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：245 / 249

页数：5

共 19 条

[1]

AMER MH, 1979, SURG GYNECOL OBSTET, V149, P687

[2] CHEMOTHERAPY OF SOLID TUMORS WITH TRIETHYLENE THIOPHOSPHORAMIDE [J].

BATEMAN, JC .

NEW ENGLAND JOURNAL OF MEDICINE, 1955, 252 (21) :879-887

[3] FURTHER COMPARATIVE TRIAL OF TRIETHYLENE THIOPHOSPHORAMIDE + MECHLORETHAMINE IN PATIENTS WITH MELANOMA + HODGKINS DISEASE [J].

BRINDLEY, CO ;

REGELSON, W ;

SHNIDER, BI ;

SALVIN, LG ;

LIPOWSKA, B ;

COLSKY, J ;

POTEE, KG .

JOURNAL OF CHRONIC DISEASES, 1964, 17 (01) :19-&

[4]

COMIS RL, 1976, CANCER TREAT REP, V60, P165

[5] HIGH-DOSE COMBINATION ALKYLATING AGENT CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT FOR METASTATIC BREAST-CANCER [J].

EDER, JP ;

ANTMAN, K ;

PETERS, W ;

HENNER, WD ;

ELIAS, A ;

SHEA, T ;

SCHRYBER, S ;

ANDERSEN, J ;

COME, S ;

SCHNIPPER, L ;

FREI, E .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) :1592-1597

[6] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY [J].

FREI, E ;

CANELLOS, GP .

AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :585-594

[7]

HERZIG GP, 1981, PROG HEMATOL, V12, P1

[8]

HERZIG R, 1984, P AN M AM SOC CLIN, V3, P264

[9]

HERZIG R, 1988, P AN M AM SOC CLIN, V7, P74

[10]

HERZIG RH, 1987, ADV CANCER CHEMOTHER, P17

← 1 2 →